Motoyasu Ozawa

Title: Motoyasu Ozawa: Innovator in Therapeutic Compounds

Introduction

Motoyasu Ozawa is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. His work focuses on compounds that exhibit selective actions beneficial for treating various medical conditions.

Latest Patents

Ozawa holds a patent for 1,5,7-trisubstituted indoline compounds and their salts. These indoline compounds are represented by a specific chemical formula, wherein R denotes various aliphatic and aromatic groups. The compounds are designed to selectively suppress urethral contractions, making them useful as therapeutic agents for dysuria treatment with minimal hypotension effects.

Career Highlights

Motoyasu Ozawa is associated with Kissei Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative work has led to the development of compounds that address critical health issues, showcasing his expertise in medicinal chemistry.

Collaborations

Ozawa has collaborated with notable colleagues, including Masaaki Ban and Kosuke Okazaki. These partnerships have contributed to the successful development of his patented compounds and have enhanced the research capabilities within his organization.

Conclusion

Motoyasu Ozawa's contributions to the field of therapeutic compounds highlight his role as an influential inventor. His patented indoline compounds represent a significant advancement in the treatment of dysuria, showcasing the importance of innovation in medicine.